Advanced Filters
noise
Found 1,651 clinical trials
S Stina Smetana, Nurse

Role of Red Blood Cells in Cardiovascular Disease

The risk of myocardial infarction is dependent on cardiovascular risk factors including type 2 diabetes (T2D) but underlying mechanisms are poorly understood. We identified that red blood cells (RBCs) mediate beneficial cardiovascular regulatory effects under hypoxic/ischemic conditions via signaling by nitric oxide (NO) and soluble guanylate cyclase (sGC) in the …

25 - 80 years of age All Phase N/A
E Ed Longridge

Diabetes in Primary Care - Improving Classification

This study aims to evaluate the clinical utility and acceptability to patients and practitioners of running diabetes classification algorithms on primary care data to help improve diagnosis of diabetes subtypes in adults diagnosed with diabetes under the age of 50. The outputs from this research will help provide initial data …

18 years of age All Phase N/A
Y Yi-Shu Chang

Feasibility of ECG-Based Glucose Monitoring System

This is a single-center, open-label clinical trial to assess the feasibility of using ECG information in estimating glucose level continuously in adult subjects.

18 years of age All Phase N/A
N Noha A Hamdy, PhD

Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome

The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic individuals. Heart rate variability will be compared for some antidiabetic drugs used in different stages of metabolic diseases and correlated to different metabolic and inflammatory …

18 - 70 years of age All Phase N/A
X XINGZHI WANG, PHD.,MD

Effectiveness and Safety of Finerenone in Chinese CKD Patients Without Diabetes Mellitus

Background: This study aimed to evaluate the effectiveness and safety of Finerenone in patients with chronic kidney disease (CKD) without diabetes mellitus(DM), however, evidence based on both clinical trails and real-world data are limited. Methods Patients with CKD without DM were enrolled in this study from December 2022 to December …

20 - 75 years of age All Phase N/A
V Veronika Šourková

Glycemic Excursions in Patients With Type 1 Diabetes Mellitus Using Closed-loop Systems

The study aims to compare glycemic excursions during several life situations (such as periods of driving, periods of night sleep, periods of occupation, periods of physical activity, and periods of stress) in patients with type 1 diabetes treated with closed-loop system and multiple daily insulin dose therapy

18 years of age All Phase N/A
J Jinhua Yan

Android Artificial Pancreas System Use Among Patients With Type 1 Diabetes Mellitus in China

This real-world prospective study will be conducted to reveal the current status of AndroidAPS use among patients with T1DM in China, evaluate the efficacy of AndroidAPS on glycemic outcomes, and explore the potential factors affecting the time in range(70-180mg/dL) derived from continuous glucose monitoring after AndroidAPS use.

years of age All Phase N/A

Short Term Outcome of Acute Heart Failure in Diabetic and Non Diabetic Patients

Around 26 million people suffer from heart failure (HF) globally, and the prevalence is increasing with an increasing longevity, prevalence of risk factors, and improved survival in patients with cardiovascular diseases In Egypt, HF is the primary cause of hospitalization among patients aged > 65 years . Hospitalization for HF …

18 years of age All Phase N/A
D Drew Taylor, MSc, PhD

Cryopreserved Hair Follicles for Disease and Cell Replacement

To explore the application of cells expanded from plucked hair follicles after collection, transport, and cryopreservation, in disease modeling and cell-based therapies.

18 - 80 years of age All Phase N/A
M Matthew Johnson, PhD

Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)

This observational 'recruit by genotype' study aims to provide insights into the cellular and molecular pathways underlying beta cell disorders and their physiological consequences. Eligible individuals are those with and without a pathogenic genetic variant, acting as case and control, respectively. Using a "recruit by genotype" approach, the researchers will …

6 - 99 years of age All Phase N/A

Simplify language using AI